🇺🇸 FDA
Patent

US 11958894

Anti-VEGF protein compositions and methods for producing the same

granted A61KA61K38/179A61K38/1866

Quick answer

US patent 11958894 (Anti-VEGF protein compositions and methods for producing the same) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/179, A61K38/1866, A61P, A61P17/06